Træk
Arthritis
Inflammation of a joint.
Resumé
- Også kaldet
- Joint inflammation
- Kropssystem
- Abnormality of the musculoskeletal system
ReferencegenomGRCh38hg38
Positioner på gen- og variantsider følger dette valg i denne browser.
Read the genes linked to Arthritis, and the rest of your genome, with one test.
Fra 449 $Gratis forsendelse · Resultater på 6–8 uger
Bestil min Genome Test173 gener knyttet til Arthritis
Ændringer i disse gener forårsager sjældne tilstande, hvor Arthritis ses. De fleste med dette træk har ingen af disse tilstande, og et gen på denne liste siger intet om nogens eget genom.
| Gen | Hvor ofte det ses | Tilstande |
|---|---|---|
| ELF4E74 like ETS transcription factor 4 | Altid | I 1 tilstand |
| IKZF2IKAROS family zinc finger 2 | Altid | I 1 tilstand |
| LYNLYN proto-oncogene, Src family tyrosine kinase | Altid | I 1 tilstand |
| NLRP3NLR family pyrin domain containing 3 | Altid | I 5 tilstande |
| PDCD1programmed cell death 1 | Altid | I 2 tilstande |
| PLD4phospholipase D family member 4 | Altid | I 1 tilstand |
| PSTPIP1proline-serine-threonine phosphatase interacting protein 1 | Altid | I 2 tilstande |
| TBK1TANK binding kinase 1 | Altid | I 1 tilstand |
| TRAF3TNF receptor associated factor 3 | Altid | I 1 tilstand |
| ANKHANKH inorganic pyrophosphate transport regulator | Meget ofte (80–99 %) | I 1 tilstand |
| ANKRD55ankyrin repeat domain 55 | Meget ofte (80–99 %) | I 2 tilstande |
| ASAH1N-acylsphingosine amidohydrolase 1 | Meget ofte (80–99 %) | I 2 tilstande |
| ATP7BATPase copper transporting beta | Meget ofte (80–99 %) | I 1 tilstand |
| C4Acomplement C4A (Chido/Rodgers blood group) | Meget ofte (80–99 %) | I 2 tilstande |
| CCR1C-C motif chemokine receptor 1 | Meget ofte (80–99 %) | I 1 tilstand |
| CD247CD247 molecule | Meget ofte (80–99 %) | I 2 tilstande |
| CD4CD4 molecule | Meget ofte (80–99 %) | I 1 tilstand |
| CLCN7Cl-/H+ antiporter 7 | Meget ofte (80–99 %) | I 1 tilstand |
| COPAcoat protein complex I subunit alpha | Meget ofte (80–99 %) | I 1 tilstand |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Meget ofte (80–99 %) | I 1 tilstand |
| FASFas cell surface death receptor | Meget ofte (80–99 %) | I 2 tilstande |
| GLAgalactosidase alpha | Meget ofte (80–99 %) | I 1 tilstand |
| HGDhomogentisate 1,2-dioxygenase | Meget ofte (80–99 %) | I 2 tilstande |
| HLA-Bmajor histocompatibility complex, class I, B | Meget ofte (80–99 %) | I 4 tilstande |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Meget ofte (80–99 %) | I 6 tilstande |
| IFNGR1interferon gamma receptor 1 | Meget ofte (80–99 %) | I 1 tilstand |
| IL10interleukin 10 | Meget ofte (80–99 %) | I 2 tilstande |
| IL12Ainterleukin 12A | Meget ofte (80–99 %) | I 1 tilstand |
| IL12A-AS1IL12A antisense RNA 1 | Meget ofte (80–99 %) | I 1 tilstand |
| IL23Rinterleukin 23 receptor | Meget ofte (80–99 %) | I 1 tilstand |
| IL2RAinterleukin 2 receptor subunit alpha | Meget ofte (80–99 %) | I 2 tilstande |
| IL2RBinterleukin 2 receptor subunit beta | Meget ofte (80–99 %) | I 2 tilstande |
| IL6interleukin 6 | Meget ofte (80–99 %) | I 1 tilstand |
| IRF4interferon regulatory factor 4 | Meget ofte (80–99 %) | I 2 tilstande |
| KLRC4killer cell lectin like receptor C4 | Meget ofte (80–99 %) | I 1 tilstand |
| LACC1laccase domain multifunctional purine nucleosidase 1 | Meget ofte (80–99 %) | I 1 tilstand |
| MEFVMEFV innate immunity regulator, pyrin | Meget ofte (80–99 %) | I 3 tilstande |
| MIFmacrophage migration inhibitory factor | Meget ofte (80–99 %) | I 1 tilstand |
| MMP14matrix metallopeptidase 14 | Meget ofte (80–99 %) | I 1 tilstand |
| MMP2matrix metallopeptidase 2 | Meget ofte (80–99 %) | I 1 tilstand |
Vis 133 gener mere
| Gen | Hvor ofte det ses | Tilstande |
|---|---|---|
| NOD2nucleotide binding oligomerization domain containing 2 | Meget ofte (80–99 %) | I 3 tilstande |
| PTPN2protein tyrosine phosphatase non-receptor type 2 | Meget ofte (80–99 %) | I 2 tilstande |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Meget ofte (80–99 %) | I 5 tilstande |
| STAT4signal transducer and activator of transcription 4 | Meget ofte (80–99 %) | I 5 tilstande |
| TLR4toll like receptor 4 | Meget ofte (80–99 %) | I 1 tilstand |
| TNFRSF11BTNF receptor superfamily member 11b | Meget ofte (80–99 %) | I 1 tilstand |
| UBAC2UBA domain containing 2 | Meget ofte (80–99 %) | I 1 tilstand |
| AP1S3adaptor related protein complex 1 subunit sigma 3 | Ofte (30–79 %) | I 1 tilstand |
| BANK1B cell scaffold protein with ankyrin repeats 1 | Ofte (30–79 %) | I 1 tilstand |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Ofte (30–79 %) | I 1 tilstand |
| BLNKB cell linker | Ofte (30–79 %) | I 1 tilstand |
| BTKBruton tyrosine kinase | Ofte (30–79 %) | I 1 tilstand |
| C1QBcomplement C1q B chain | Ofte (30–79 %) | I 1 tilstand |
| C2orf69chromosome 2 open reading frame 69 | Ofte (30–79 %) | I 1 tilstand |
| C4Bcomplement C4B (Chido/Rodgers blood group) | Ofte (30–79 %) | I 1 tilstand |
| CAV1caveolin 1 | Ofte (30–79 %) | I 1 tilstand |
| CCN2cellular communication network factor 2 | Ofte (30–79 %) | I 1 tilstand |
| CCR6C-C motif chemokine receptor 6 | Ofte (30–79 %) | I 1 tilstand |
| CD79ACD79a molecule | Ofte (30–79 %) | I 1 tilstand |
| CD79BCD79b molecule | Ofte (30–79 %) | I 1 tilstand |
| COL2A1collagen type II alpha 1 chain | Ofte (30–79 %) | I 1 tilstand |
| CR2complement C3d receptor 2 | Ofte (30–79 %) | I 1 tilstand |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Ofte (30–79 %) | I 3 tilstande |
| DNASE1deoxyribonuclease 1 | Ofte (30–79 %) | I 2 tilstande |
| DNASE1L3deoxyribonuclease 1L3 | Ofte (30–79 %) | I 1 tilstand |
| ETS1ETS proto-oncogene 1, transcription factor | Ofte (30–79 %) | I 1 tilstand |
| FCGR2BFc gamma receptor IIb | Ofte (30–79 %) | I 2 tilstande |
| FCGR3BFc gamma receptor IIIb | Ofte (30–79 %) | I 1 tilstand |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Ofte (30–79 %) | I 1 tilstand |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Ofte (30–79 %) | I 1 tilstand |
| HPGD15-hydroxyprostaglandin dehydrogenase | Ofte (30–79 %) | I 3 tilstande |
| IGHG1immunoglobulin heavy constant gamma 1 (G1m marker) | Ofte (30–79 %) | I 1 tilstand |
| IGHMimmunoglobulin heavy constant mu | Ofte (30–79 %) | I 1 tilstand |
| IGLL1immunoglobulin lambda like polypeptide 1 | Ofte (30–79 %) | I 1 tilstand |
| IL12Binterleukin 12B | Ofte (30–79 %) | I 1 tilstand |
| IL36RNinterleukin 36 receptor antagonist | Ofte (30–79 %) | I 1 tilstand |
| IRAK1interleukin 1 receptor associated kinase 1 | Ofte (30–79 %) | I 2 tilstande |
| IRF5interferon regulatory factor 5 | Ofte (30–79 %) | I 2 tilstande |
| ITGAMintegrin subunit alpha M | Ofte (30–79 %) | I 1 tilstand |
| JAZF1JAZF zinc finger 1 | Ofte (30–79 %) | I 1 tilstand |
| KIAA0319LKIAA0319 like | Ofte (30–79 %) | I 1 tilstand |
| KNSTRNkinetochore localized astrin (SPAG5) binding protein | Ofte (30–79 %) | I 2 tilstande |
| LBRlamin B receptor | Ofte (30–79 %) | I 1 tilstand |
| LMX1BLIM homeobox transcription factor 1 beta | Ofte (30–79 %) | I 1 tilstand |
| LRRC8Aleucine rich repeat containing 8 VRAC subunit A | Ofte (30–79 %) | I 1 tilstand |
| MECP2methyl-CpG binding protein 2 | Ofte (30–79 %) | I 1 tilstand |
| MLXMAX dimerization protein MLX | Ofte (30–79 %) | I 1 tilstand |
| MVKmevalonate kinase | Ofte (30–79 %) | I 2 tilstande |
| OCRLOCRL inositol polyphosphate-5-phosphatase | Ofte (30–79 %) | I 1 tilstand |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Ofte (30–79 %) | I 1 tilstand |
| PIK3CDphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | Ofte (30–79 %) | I 3 tilstande |
| PIK3R1phosphoinositide-3-kinase regulatory subunit 1 | Ofte (30–79 %) | I 1 tilstand |
| PRKCDprotein kinase C delta | Ofte (30–79 %) | I 1 tilstand |
| PRPS1phosphoribosyl pyrophosphate synthetase 1 | Ofte (30–79 %) | I 2 tilstande |
| PRTN3proteinase 3 | Ofte (30–79 %) | I 1 tilstand |
| PXKPX domain containing serine/threonine kinase like | Ofte (30–79 %) | I 1 tilstand |
| SHARPINSHANK associated RH domain interactor | Ofte (30–79 %) | I 1 tilstand |
| SLCO2A1solute carrier organic anion transporter family member 2A1 | Ofte (30–79 %) | I 1 tilstand |
| SPI1Spi-1 proto-oncogene | Ofte (30–79 %) | I 1 tilstand |
| SPP1secreted phosphoprotein 1 | Ofte (30–79 %) | I 2 tilstande |
| TCF3transcription factor 3 | Ofte (30–79 %) | I 1 tilstand |
| TLR7toll like receptor 7 | Ofte (30–79 %) | I 1 tilstand |
| TNFAIP3TNF alpha induced protein 3 | Ofte (30–79 %) | I 1 tilstand |
| TNFRSF1ATNF receptor superfamily member 1A | Ofte (30–79 %) | I 1 tilstand |
| TNFSF4TNF superfamily member 4 | Ofte (30–79 %) | I 1 tilstand |
| TNIP1TNFAIP3 interacting protein 1 | Ofte (30–79 %) | I 1 tilstand |
| TREX1three prime repair exonuclease 1 | Ofte (30–79 %) | I 3 tilstande |
| UBE2L3ubiquitin conjugating enzyme E2 L3 | Ofte (30–79 %) | I 1 tilstand |
| ACP5acid phosphatase 5, tartrate resistant | Nogle gange (5–29 %) | I 1 tilstand |
| ADARadenosine deaminase RNA specific | Nogle gange (5–29 %) | I 1 tilstand |
| AGAaspartylglucosaminidase | Nogle gange (5–29 %) | I 1 tilstand |
| ARVCFARVCF delta catenin family member | Nogle gange (5–29 %) | I 1 tilstand |
| BMP6bone morphogenetic protein 6 | Nogle gange (5–29 %) | I 1 tilstand |
| BTNL2butyrophilin like 2 | Nogle gange (5–29 %) | I 1 tilstand |
| COMTcatechol-O-methyltransferase | Nogle gange (5–29 %) | I 1 tilstand |
| EPCAMepithelial cell adhesion molecule | Nogle gange (5–29 %) | I 2 tilstande |
| EXT1exostosin glycosyltransferase 1 | Nogle gange (5–29 %) | I 1 tilstand |
| EXT2exostosin glycosyltransferase 2 | Nogle gange (5–29 %) | I 1 tilstand |
| FOXP3forkhead box P3 | Nogle gange (5–29 %) | I 1 tilstand |
| GJB2gap junction protein beta 2 | Nogle gange (5–29 %) | I 1 tilstand |
| GJB6gap junction protein beta 6 | Nogle gange (5–29 %) | I 1 tilstand |
| GP1BBglycoprotein Ib platelet subunit beta | Nogle gange (5–29 %) | I 1 tilstand |
| HFEhomeostatic iron regulator | Nogle gange (5–29 %) | I 1 tilstand |
| HIRAhistone cell cycle regulator | Nogle gange (5–29 %) | I 1 tilstand |
| HNF1BHNF1 homeobox B | Nogle gange (5–29 %) | I 1 tilstand |
| IFIH1interferon induced with helicase C domain 1 | Nogle gange (5–29 %) | I 2 tilstande |
| IGHG2immunoglobulin heavy constant gamma 2 (G2m marker) | Nogle gange (5–29 %) | I 1 tilstand |
| IGKCimmunoglobulin kappa constant | Nogle gange (5–29 %) | I 1 tilstand |
| JMJD1Cjumonji domain containing 1C | Nogle gange (5–29 %) | I 1 tilstand |
| LRBALPS responsive beige-like anchor protein | Nogle gange (5–29 %) | I 1 tilstand |
| LSM11LSM11, U7 small nuclear RNA associated | Nogle gange (5–29 %) | I 1 tilstand |
| PHEXphosphate regulating endopeptidase X-linked | Nogle gange (5–29 %) | I 1 tilstand |
| RNASEH2Aribonuclease H2 subunit A | Nogle gange (5–29 %) | I 1 tilstand |
| RNASEH2Bribonuclease H2 subunit B | Nogle gange (5–29 %) | I 1 tilstand |
| RNASEH2Cribonuclease H2 subunit C | Nogle gange (5–29 %) | I 1 tilstand |
| RNF168ring finger protein 168 | Nogle gange (5–29 %) | I 1 tilstand |
| RNU7-1RNA, U7 small nuclear 1 | Nogle gange (5–29 %) | I 1 tilstand |
| RREB1ras responsive element binding protein 1 | Nogle gange (5–29 %) | I 1 tilstand |
| SAMHD1SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 | Nogle gange (5–29 %) | I 1 tilstand |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Nogle gange (5–29 %) | I 1 tilstand |
| SEC24CSEC24 homolog C, COPII component | Nogle gange (5–29 %) | I 1 tilstand |
| SYKspleen associated tyrosine kinase | Nogle gange (5–29 %) | I 1 tilstand |
| TBX1T-box transcription factor 1 | Nogle gange (5–29 %) | I 1 tilstand |
| TFtransferrin | Nogle gange (5–29 %) | I 1 tilstand |
| THSD4thrombospondin type 1 domain containing 4 | Nogle gange (5–29 %) | I 1 tilstand |
| UFD1ubiquitin recognition factor in ER associated degradation 1 | Nogle gange (5–29 %) | I 1 tilstand |
| VPS13Avacuolar protein sorting 13 homolog A | Nogle gange (5–29 %) | I 1 tilstand |
| WASWASP actin nucleation promoting factor | Nogle gange (5–29 %) | I 1 tilstand |
| XIAPX-linked inhibitor of apoptosis | Nogle gange (5–29 %) | I 1 tilstand |
| CASP10caspase 10 | Sjældent (1–4%) | I 1 tilstand |
| FASLGFas ligand | Sjældent (1–4%) | I 1 tilstand |
| FGF10fibroblast growth factor 10 | Sjældent (1–4%) | I 1 tilstand |
| FGFR2fibroblast growth factor receptor 2 | Sjældent (1–4%) | I 1 tilstand |
| FGFR3fibroblast growth factor receptor 3 | Sjældent (1–4%) | I 1 tilstand |
| KRT5keratin 5 | Sjældent (1–4%) | I 1 tilstand |
| MYH14myosin heavy chain 14 | Sjældent (1–4%) | I 1 tilstand |
| POFUT1protein O-fucosyltransferase 1 | Sjældent (1–4%) | I 1 tilstand |
| POGLUT1protein O-glucosyltransferase 1 | Sjældent (1–4%) | I 1 tilstand |
| PSENENpresenilin enhancer, gamma-secretase subunit | Sjældent (1–4%) | I 1 tilstand |
| ABCG2ATP binding cassette subfamily G member 2 (JR blood group) | Ikke registreret | I 1 tilstand |
| ABCG8ATP binding cassette subfamily G member 8 | Ikke registreret | I 1 tilstand |
| ADA2adenosine deaminase 2 | Ikke registreret | I 1 tilstand |
| FCGR2AFc gamma receptor IIa | Ikke registreret | I 1 tilstand |
| HJVhemojuvelin BMP co-receptor | Ikke registreret | I 1 tilstand |
| HLA-Cmajor histocompatibility complex, class I, C | Ikke registreret | I 1 tilstand |
| HOXD10homeobox D10 | Ikke registreret | I 1 tilstand |
| NLRP12NLR family pyrin domain containing 12 | Ikke registreret | I 1 tilstand |
| PRG4proteoglycan 4 | Ikke registreret | I 1 tilstand |
| PSMB4proteasome 20S subunit beta 4 | Ikke registreret | I 1 tilstand |
| RAG1recombination activating 1 | Ikke registreret | I 1 tilstand |
| RAG2recombination activating 2 | Ikke registreret | I 1 tilstand |
| TFR2transferrin receptor 2 | Ikke registreret | I 1 tilstand |
| UBA1ubiquitin like modifier activating enzyme 1 | Ikke registreret | I 1 tilstand |
Hvor hyppigt det ses hos personer med en af genets tilstande, den hyppigste værdi på tværs af dem, sådan som Human Phenotype Ontology registrerer det. Disse sider beskriver egenskaber og den forskning, der ligger bag dem. De er ikke en diagnose, og hvis du har spørgsmål om symptomer, bør du spørge en læge eller genetisk rådgiver.
Snævrere træk
Bredere træk
Hvor oplysningerne kommer fra
- Human Phenotype Ontology, udgivelse 2026-09-01: egenskaben, dens navne, definition og de gener, der er knyttet til den. Læs mere på hpo.jax.org.
- Dataudgivelse 2026.10.16-c6eea6bf.
Én test. Svar for hele livet.
Fra 449 $Gratis forsendelse · Resultater på 6–8 uger